- AU$31.98m
- AU$33.34m
- AU$28.64m
- 66
- 72
- 42
- 63
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.7 | 46.6 | 25.3 | 19 | 28.6 |
Cost of Revenue | |||||
Gross Profit | 13.7 | 22.6 | 19.1 | 12.3 | 18.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.5 | 41.4 | 17.9 | 19.9 | 29.4 |
Operating Profit | -4.83 | 5.2 | 7.4 | -0.916 | -0.805 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.73 | 4.95 | 6.69 | -0.358 | -0.844 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.73 | 4.94 | 6.67 | -0.662 | -1.05 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.72 | 4.94 | 13.7 | 33.1 | -1.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.72 | 4.94 | 13.7 | 33.1 | -1.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.022 | 0.02 | 0.027 | -0.003 | -0.004 |
Special Dividends per Share |